Pharmacokinetic profile of a novel sustained-release caffeine with extended benefits on alertness and mood: A randomized, double-blind, single-dose, active-controlled, crossover study

Pharmacokinetic profile of a novel sustained-release caffeine with extended benefits on alertness and mood: A randomized, double-blind, single-dose, active-controlled, crossover study

Background: Oral consumption of caffeine typically leads to its instant release and subsequent rapid absorption, high plasma caffeine levels followed by a quick steep decline reducing its beneficial effects which is frequently referred to as “caffeine crash”. To overcome this limitation, we develope...

Full description

Bibliographic Details
Main Authors: Abhijeet Morde, Kothapally Sudhakar, Maddela Rambabu, Alukapally Shankar, Deshanie Rai, Krishnaji Pawar, Manutosh Acharya, Munja Bakan, Pravin Nalawade, Ravindra Nayakwadi, Muralidhara Padigaru
Format: Article
Language:English
Published: Elsevier 2021-11-01
Series:Current Research in Behavioral Sciences
Subjects:
Sustained-release caffeine
Caff
VAS
Psychostimulant
Pharmacokinetics
Mood
Online Access:http://www.sciencedirect.com/science/article/pii/S2666518221000231

Internet

http://www.sciencedirect.com/science/article/pii/S2666518221000231

Similar Items